Millipore Sigma Vibrant Logo

324470 E-4031 - CAS 113558-89-7 - Calbiochem

A potent and selective inhibitor of the rapid type of inactivating inward-rectifying K+ current (IK, IR) (IC₅₀ = 10 nM).

E-4031 - CAS 113558-89-7 - Calbiochem: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: 4ʹ-[[1-[2-(6-Methyl-2-pyridinyl)ethyl-4-piperidinyl]carbonyl]methanesulfonanilide, 2HCl

Primary Target: Inhibitor of the rapid type of inactivating inward-rectifying K+ current
View Products on Sigmaaldrich.com
324470
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
113558-89-7C₂₁H₂₇N₃O₃S · 2HCl · 2H₂O

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
324470-5MG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Glasflasche 5 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewA potent and selective inhibitor of the rapid type of inactivating inward-rectifying K+ current (IK, IR) (IC50 = 10 nM). A class III anti-arrhythmic agent with differential atrial versus ventricular activity. A specific blocker of HERG channels (IC50 = 7.7 nM).
      Catalogue Number324470
      Brand Family Calbiochem®
      Synonyms4ʹ-[[1-[2-(6-Methyl-2-pyridinyl)ethyl-4-piperidinyl]carbonyl]methanesulfonanilide, 2HCl
      References
      ReferencesFicker, E., et al. 2000. Am. J. Physiol. 279, H1748.
      Ono, K., et al. 2000. J. Physiol. (London) 524 (Pt. 1), 51.
      Xie, J.T., et al. 2000. Methods Find. Exp. Clin. Pharmacol. 22, 67.
      Bauer, C.K., et al. 1999. Mol. Cell Endocrinol. 148, 37.
      Baskin, E.P., and Lynch, J.J. 1998. J. Pharmacol. Exp. Ther. 285, 135.
      Weinsberg, F., et al. 1997. Pflugers Arch. 434, 1.
      West, P.D., et al. 1997. J. Cardiovasc. Pharmacol. Ther. 2, 205.
      West, P.D., et al. 1996. Pharmacol. Toxicol. 78, 89.
      Product Information
      CAS number113558-89-7
      ATP CompetitiveN
      FormWhite to off-white solid
      Hill FormulaC₂₁H₂₇N₃O₃S · 2HCl · 2H₂O
      Chemical formulaC₂₁H₂₇N₃O₃S · 2HCl · 2H₂O
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetInhibitor of the rapid type of inactivating inward-rectifying K+ current
      Primary Target IC<sub>50</sub>10 nM inhibiting the rapid type of inactivating inward-rectifying K+ current
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      324470-5MG 04055977197228

      Documentation

      E-4031 - CAS 113558-89-7 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      E-4031 - CAS 113558-89-7 - Calbiochem Analysenzertifikate

      TitelChargennummer
      324470

      Literatur

      Übersicht
      Ficker, E., et al. 2000. Am. J. Physiol. 279, H1748.
      Ono, K., et al. 2000. J. Physiol. (London) 524 (Pt. 1), 51.
      Xie, J.T., et al. 2000. Methods Find. Exp. Clin. Pharmacol. 22, 67.
      Bauer, C.K., et al. 1999. Mol. Cell Endocrinol. 148, 37.
      Baskin, E.P., and Lynch, J.J. 1998. J. Pharmacol. Exp. Ther. 285, 135.
      Weinsberg, F., et al. 1997. Pflugers Arch. 434, 1.
      West, P.D., et al. 1997. J. Cardiovasc. Pharmacol. Ther. 2, 205.
      West, P.D., et al. 1996. Pharmacol. Toxicol. 78, 89.

      Literaturstellen

      Titel
    • Jun Guo, Hongying Gang and Shetuan Zhang. (2006) Molecular Determinants of Cocaine Block of Human Ether-a-go-go-Related Gene Potassium Channels. Journal of Pharmacology and Experimental Therapeutics 317, 865-874.
      		•
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision10-December-2016 JSW
      Synonyms4ʹ-[[1-[2-(6-Methyl-2-pyridinyl)ethyl-4-piperidinyl]carbonyl]methanesulfonanilide, 2HCl
      DescriptionA potent and selective inhibitor of the inactivating inward-rectifying potassium current (IK,IR) (IC50 = 10 nM). In inside-out patches, E-4031 also blocks ATP sensitive K+ channel (EC50 = 31 µM). A specific blocker of cardiac HERG channels (IC50 = 7.7 nM). A class III anti-arrhythmic agent with differential atrial versus ventricular activity.
      FormWhite to off-white solid
      CAS number113558-89-7
      Chemical formulaC₂₁H₂₇N₃O₃S · 2HCl · 2H₂O
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (50 mg/ml) or H₂O (50 mg/ml)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesFicker, E., et al. 2000. Am. J. Physiol. 279, H1748.
      Ono, K., et al. 2000. J. Physiol. (London) 524 (Pt. 1), 51.
      Xie, J.T., et al. 2000. Methods Find. Exp. Clin. Pharmacol. 22, 67.
      Bauer, C.K., et al. 1999. Mol. Cell Endocrinol. 148, 37.
      Baskin, E.P., and Lynch, J.J. 1998. J. Pharmacol. Exp. Ther. 285, 135.
      Weinsberg, F., et al. 1997. Pflugers Arch. 434, 1.
      West, P.D., et al. 1997. J. Cardiovasc. Pharmacol. Ther. 2, 205.
      West, P.D., et al. 1996. Pharmacol. Toxicol. 78, 89.
      Citation
    • Jun Guo, Hongying Gang and Shetuan Zhang. (2006) Molecular Determinants of Cocaine Block of Human Ether-a-go-go-Related Gene Potassium Channels. Journal of Pharmacology and Experimental Therapeutics 317, 865-874.
      		•